To hear health officials in the Trump administration talk, artificial intelligence has arrived in Washington to fast-track new life-saving drugs to market, streamline work at the vast, ...
Panelists discuss how recent FDA approvals and SC amivantamab data support broader use of subcutaneous therapy in NSCLC.
Hosted on MSN
The FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes
As CNN reports, six current and former FDA officials are warning that the AI, dubbed Elsa, which was unveiled weeks earlier, is "hallucinating" completely made-up studies. It's a terrifying reality ...
The Food and Drug Administration is planning to use artificial intelligence to “radically increase efficiency” in deciding whether to approve new drugs and devices, one of several top priorities laid ...
WASHINGTON, Aug 5 (Reuters) - OpenAI's ChatGPT, Google's Gemini and Anthropic's Claude have been added to a list of approved AI vendors, the U.S. government's central purchasing arm said on Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback